A Study of Itacitinib for the Prevention of Cytokine Release Syndrome Induced by Immune Effector Cell Therapy
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to YESCARTA
Related studies linked through entity extraction aliases.
MT2017-45: CAR-T Cell Therapy for Heme Malignancies
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2